Long-Term Prognostic Value of 18F-FDG PET in Patients with Locally Advanced Rectal Cancer Previously Treated with Neoadjuvant Radiochemotherapy
Carlo Capirci1,
Domenico Rubello2,
Franca Chierichetti3,
Giorgio Crepaldi4,
Stefano Fanti5,
Giovanni Mandoliti1,
Simonetta Salviato6,
Giuseppe Boni7,
Lucia Rampin2,
Cesare Polico1 and
Giuliano Mariani7
1 Radiotherapy Department, S. Maria della Misericordia Hospital, Rovigo,
Italy.
2 Nuclear Medicine Service-PET Unit, S. Maria della Misericordia Hospital,
Rovigo, Italy.
3 Nuclear Medicine Service-PET Center, Castelfranco Veneto General Hospital,
Castelfranco Veneto, Italy.
4 Medical Oncology Department, S. Maria della Misericordia Hospital, Rovigo,
Italy.
5 Nuclear Medicine Service-PET Unit, S. Orsola-Malpighi Hospital, University of
Bologna Medical School, Bologna, Italy.
6 Health Physics Service, S. Maria della Misericordia Hospital, Rovigo,
Italy.
7 Regional Center of Nuclear Medicine, University of Pisa Medical School, Via
Roma 67, Pisa, Italy I-56126.

View larger version (44K):
[in a new window]
|
Fig. 1 Representative examples of after-radiochemotherapy
18F-FDG PET scans (transaxial sections at perineal level) obtained
in patients with rectal cancer after completion of neoadjuvant therapy.
A-E Tracer uptake by tumor was scored as intense (SUVmax =
15.4) in 67-year-old man (A), moderate (SUVmax = 5.6) in
52-year-old man (B), mild (SUVmax = 2.3) in 55-year-old
woman (C), faint (SUVmax = 1.2) in 50-year-old woman
(D), and absent (SUVmax = 0.7) in 48-year-old man
(E). Accumulation of radioactivity in bladder provides useful anatomic
landmark for topographic reference. SUVmax = maximum standardized
uptake value. Arrows are computer-generated and have no particular
meaning.
|
|

View larger version (13K):
[in a new window]
|
Fig. 2 Kaplan-Meier plot of patterns of disease-free survival,
overall survival, and survival free from local recurrences in whole group of
88 patients with advanced rectal cancer.
|
|

View larger version (15K):
[in a new window]
|
Fig. 3 Kaplan-Meier plot of pattern of disease-free survival as
function of pathologic stage assessed at surgery.
|
|

View larger version (10K):
[in a new window]
|
Fig. 4 Kaplan-Meier plot of pattern of disease-free survival as
function of after-radiochemotherapy 18F-FDG PET findings (54
patients with negative [], 34 patients with positive [ ] PET
findings after neoadjuvant radiochemotherapy).
|
|

View larger version (13K):
[in a new window]
|
Fig. 5 Kaplan-Meier plot of pattern of disease-free survival as
function of combined after-radiochemotherapy 18F-FDG PET findings
and pathologic stage.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2006 by the American Roentgen Ray Society.